title: Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by pingchuan yiqi granule.
abstract: OBJECTIVE
  To evaluate the effect and safety of Pingchuan Yiqi Granule in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC).
  
  
  METHODS
  With the randomized, positive agent parallel controlled design adopted, the 80 subjects enrolled were assigned in the ratio of 3:1 to two groups, the 60 patients in the trial group were treated with PYG and the 20 in the control group treated with Ruyi Dingchuan Pill (RDP), with the therapeutic course consisting of 7 days for both groups. The clinical effects, effects on TCM syndrome and the changes of lung function after treatment were observed.
  
  
  RESULTS
  The effect of the treatment on asthma in the trial group: clinically controlled rate was 6.67%, markedly effective rate 51.67%, improved rate 33.33% and ineffective rate 8.33%; and the corresponding rates in the control group were 5.00%, 50.00%, 30.00%, and 15.00% respectively. Comparison between the two groups showed insignificant difference (P>0.05). The effect on TCM syndrome in the treated group: clinically controlled rate was 11.67%, markedly effective rate 58.33%, effective rate 21.67% and ineffective rate 8.33%; and those in the control group were 10.00%, 50.00%, 30.00% and 10.00% respectively, also showing insignificant difference between the two groups (P>0.05). Lung function test showed that the change on forced expiratory volume in 1 second (FEV1) after treatment in the trial group was of statistical significance (P<0.05), but no significant difference was shown in the change of peak expiratory flow (PEF, P>0.05); while the changes in the control group were just the opposite, showing insignificance in FEV1 (P>0.05) but significance in PEF (P<0.05). Comparison of the therapeutic effect on lung function between the two groups showed no significant difference (P>0.05). No adverse reaction was found in either group in the course of treatment.
  
  
  CONCLUSIONS
  PYG used to treat BS-QDC is effective and safe, it's effect is similar to that of RDP.
authors.affiliation: Department of Integrative Chinese and Western Medicine, Huaxi Hospital of Sichuan University, Chengdu 610041. zhangyingsl@sohu.com
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhang
authors.forename: Jing
authors.initials: J
authors.lastname: Chang
authors.forename: Huan-hai
authors.initials: HH
authors.lastname: Chi
authors.forename: Bing
authors.initials: B
authors.lastname: Mao
authors.forename: Wen-fu
authors.initials: WF
authors.lastname: Tang
authors.forename: Lei
authors.initials: L
authors.lastname: Wang
authors.forename: Su-zhen
authors.initials: SZ
authors.lastname: Huang
authors.forename: Ting-qian
authors.initials: TQ
authors.lastname: Li
authors.forename: Rui-ming
authors.initials: RM
authors.lastname: Zhang
mesh_terms: D000328:Adult; D001249:Asthma / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D003139:Common Cold / Q000150:complications* / Q000503:physiopathology*; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D019413:Qi; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D004365:Drugs, Chinese Herbal; C521735:pingchuan yiqi